A Host-specific, temperature-sensitive translation defect determines the attenuation phenotype of a human rhinovirus/poliovirus chimera, PV1(RIPO)

Journal of Virology

Volumn 85, Issue 14, 2011, Pages 7225-7235

  Jahan, Nusrat ^a   Wimmer, Eckard ^a   Mueller, Steffen ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CHIMERA; GENE MUTATION; GENETIC VARIABILITY; HOST RANGE; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; MOUSE; NERVE CELL; NONHUMAN; PHENOTYPE; POLIOMYELITIS VIRUS 1; POLIOMYELITIS VIRUS 1 (RIPO); PRIORITY JOURNAL; RHINOVIRUS; RNA TRANSLATION; TEMPERATURE SENSITIVITY; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; HUMANS; MICE; PHENOTYPE; POLIOVIRUS; PROTEIN BIOSYNTHESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINOVIRUS; TEMPERATURE; VIRUS REPLICATION;

HUMAN RHINOVIRUS SP.; MACACA FASCICULARIS; MURINAE; MUS; MUS MUSCULUS; POLIOVIRUS; PRIMATES;

EID: 79960397102     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01804-09     Document Type: Article

References (64)

1. Alexander, L., H. H. Lu, and E. Wimmer. 1994. Polioviruses containing picornavirus type 1 and/or type 2 IRES elements: genetic hybrids and the expression of a foreign gene. Proc. Natl. Acad. Sci. U. S. A. 91:1406-1410.
2. Bernhardt, G., J. A. Bibb, J. Bradley, and E. Wimmer. 1994. Molecular characterization of the cellular receptor for poliovirus. Virology 199:105-113.
3. Caliguiri, L. A., and I. Tamm. 1968. Action of guanidine on the replication of poliovirus RNA. Virology 35:408-417.
4. Campbell, S. A., J. Lin, E. Y. Dobrikova, and M. Gromeier. 2005. Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells. J. Virol. 79:6281-6290.
5. Cello, J., A. Paul, and E. Wimmer. 2002. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 297:1016-1018.
6. Cello, J., et al. 2008. Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses. J. Med. Virol. 80:352-359.
7. Chumakov, K., et al. 2001. Inactivated vaccines based on alternatives to wild-type seed virus. Dev. Biol. (Basel) 105:171-177.
8. De Jesus, N., D. Franco, A. Paul, E. Wimmer, and J. Cello. 2005. Mutation of a single conserved nucleotide between the cloverleaf and internal ribosome entry site attenuates poliovirus neurovirulence. J. Virol. 79:14235-14243.
9. Dobrikova, E., P. Florez, S. Bradrick, and M. Gromeier. 2003. Activity of a type 1 picornavirus internal ribosomal entry site is determined by sequences within the 3′ nontranslated region. Proc. Natl. Acad. Sci. U. S. A. 100:15125-15130.
10. Dolan, T. M., J. D. Fenters, P. A. Fordyce, and J. C. Holper. 1968. Rhinovirus plaque formation in WI-38 cells with methylcellulose overlay. Appl. Microbiol. 16:1331-1336.
11. Dunn, G., N. T. Begg, N. Cammack, and P. D. Minor. 1990. Virus excretion and mutation by infants following primary vaccination with live oral polio-vaccine from two sources. J. Med. Virol. 32:92-95.
12. Ehrenfeld, E., and N. L. Teterina. 2002. Initiation of translation of picornavirus RNAs: structure and function of the internal ribosome entry site, p. 159-169. In B. L. Semler and E. Wimmer (ed.), Molecular biology of picornaviruses. ASM Press, Washington, DC.
13. Goetz, C., R. G. Everson, L. C. Zhang, and M. Gromeier. 2010. MAPK signal-integrating kinase controls cap-independent translation and cell typespecific cytotoxicity of an oncolytic poliovirus. Mol. Ther. 18:1937-1946.
14. Goetz, C., and M. Gromeier. 2010. Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme. Cytokine Growth Factor Rev. 21:197-203.
15. Gromeier, M., L. Alexander, and E. Wimmer. 1996. Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc. Natl. Acad. Sci. U. S. A. 93:2370-2375.
16. Gromeier, M., B. Bossert, M. Arita, A. Nomoto, and E. Wimmer. 1999. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J. Virol. 73:958-964.
17. Gromeier, M., S. Lachmann, M. R. Rosenfeld, P. H. Gutin, and E. Wimmer. 2000. Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc. Natl. Acad. Sci. U. S. A. 97:6803-6808.
18. Gromeier, M., et al. 1997. Determinants of poliovirus neurovirulence. J. Neurovirol. 3(Suppl. 1):S35-S38.
19. Harris, J. R., and V. R. Racaniello. 2003. Changes in rhinovirus protein 2C allow efficient replication in mouse cells. J. Virol. 77:4773-4780.
20. Harris, J. R., and V. R. Racaniello. 2005. Amino acid changes in proteins 2B and 3A mediate rhinovirus type 39 growth in mouse cells. J. Virol. 79:5363-5373.
21. Ida-Hosonuma, M., et al. 2005. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 79:4460-4469.
22. Iwasaki, A., et al. 2002. Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection. J. Infect. Dis. 186:585-592.
23. Jacobson, M. F., and D. Baltimore. 1968. Morphogenesis of poliovirus. I. Association of the viral RNA with coat protein. J. Mol. Biol. 33:369-378.
24. Jang, S. K., et al. 1988. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62:2636-2643.
25. Kauder, S., S. Kan, and V. R. Racaniello. 2006. Age-dependent poliovirus replication in the mouse central nervous system is determined by internal ribosome entry site-mediated translation. J. Virol. 80:2589-2595.
26. Kauder, S. E., and V. R. Racaniello. 2004. Poliovirus tropism and attenuation are determined after internal ribosome entry. J. Clin. Invest. 113:1743-1753.
27. Kohara, M., et al. 1985. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. J. Virol. 53:786-792.
28. Koike, S., et al. 1991. Transgenic mice susceptible to poliovirus. Proc. Natl. Acad. Sci. U. S. A. 88:951-955.
29. Koike, S., et al. 1990. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 9:3217-3224.
30. La Monica, N., J. W. Almond, and V. R. Racaniello. 1987. A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans. J. Virol. 61(9):2917-2920.
31. La Monica, N., and V. R. Racaniello. 1989. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J. Virol. 63:2357-2360.
32. Li, X., H. H. Lu, S. Mueller, and E. Wimmer. 2001. The C-terminal residues of poliovirus proteinase 2A(pro) are critical for viral RNA replication but not for cisor trans-proteolytic cleavage. J. Gen. Virol. 82:397-408.
33. Loddo, B., W. Ferrari, G. Brotzu, and A. Spanedda. 1962. In vitro inhibition of infectivity of polio viruses by guanidine. Nature 193:97-98.
34. Lomax, N. B., and F. H. Yin. 1989. Evidence for the role of the P2 protein of human rhinovirus in its host range change. J. Virol. 63:2396-2399.
35. Lu, H. H., and E. Wimmer. 1996. Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 93:1412-1417.
36. Martínez-Salas, E., and M. D. Ryan. 2010. Translation and protein processing, p. 141-161. In E. Ehrenfeld, E. Domingo, and R. P. Roos (ed.), The picornaviruses. ASM Press, Washington, DC.
37. Mendelsohn, C. L., E. Wimmer, and V. R. Racaniello. 1989. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56:855-865.
38. Molla, A., A. V. Paul, and E. Wimmer. 1991. Cell-free, de novo synthesis of poliovirus. Science 254:1647-1651.
39. Mueller, S., and E. Wimmer. 2003. Recruitment of nectin-3 to cell-cell junctions through trans-heterophilic interaction with CD155, a vitronectin and poliovirus receptor that localizes to alpha (v) beta3 integrin-containing membrane microdomains. J. Biol. Chem. 278:31251-31260.
40. Mueller, S., D. Papamichail, J. R. Coleman, S. Skiena, and E. Wimmer. 2006. Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity. J. Virol. 80:9687-9696.
41. Mueller, S., E. Wimmer, and J. Cello. 2005. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event. Virus Res. 111:175-193.
42. Ochiai, H., et al. 2004. Treatment of intracerebral neoplasia and neoplastic meningitis with regional delivery of oncolytic recombinant poliovirus. Clin. Cancer Res. 10:4831-4838.
43. Ohka, S., et al. 2007. Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor. J. Virol. 81:7902-7912.
44. Paul, A. V. 2002. Possible unifying mechanism of picornavirus genome replication, p. 227-246. In B. L. Semler and E. Wimmer (ed.), Molecular biology of picornaviruses. ASM Press, Washington, DC.
45. Pelletier, J., and N. Sonenberg. 1988. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334:320-325.
46. Pfister, T., and E. Wimmer. 1999. Characterization of the nucleoside triphosphatase activity of poliovirus protein 2C reveals a mechanism by which guanidine inhibits poliovirus replication. J. Biol. Chem. 274:6992-7001.
47. Pilipenko, E. V., E. G. Viktorova, S. T. Guest, V. I. Agol, and R. P. Roos. 2001. Cell-specific proteins regulate viral RNA translation and virus-induced disease. EMBO J. 20:6899-6908.
48. Pipkin, P. A., D. J. Wood, V. R. Racaniello, and P. D. Minor. 1993. Characterisation of L cells expressing the human poliovirus receptor for the specific detection of polioviruses in vitro. J. Virol. Methods 41:333-340.
49. Reed, L. J., and M. Muench. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hyg. (Lond.) 27:493-497.
50. Ren, R., F. Costantini, E. J. Gorgacz, J. J. Lee, and V. R. Racaniello. 1990. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63:353-362.
51. Ren, R., and V. R. Racaniello. 1992. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J. Virol. 66:296-304.
52. Shaw, G., S. Morse, M. Ararat, and F. L. Graham. 2002. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16:869-871.
53. Shiroki, K., et al. 1995. A new cis-acting element for RNA replication within the 5′ noncoding region of poliovirus type 1 RNA. J. Virol. 69:6825-6832.
54. Solecki, D., S. Schwarz, E. Wimmer, M. Lipp, and G. Bernhardt. 1997. The promoters for human and monkey poliovirus receptors. Requirements for basic and cell type-specific activity. J. Biol. Chem. 272:5579-5586.
55. Svitkin, Y. V., T. V. Pestova, S. V. Maslova, and V. I. Agol. 1988. Point mutations modify the response of poliovirus RNA to a translation initiation factor: a comparison of neurovirulent and attenuated strains. Virology 166: 394-404.
56. Toyoda, H., D. Franco, K. Fujita, A. V. Paul, and E. Wimmer. 2007. Replication of poliovirus requires binding of the poly(rC) binding protein to the cloverleaf as well as to the adjacent C-rich spacer sequence between the cloverleaf and the internal ribosomal entry site. J. Virol. 81:10017-10028.
57. Toyoda, H., J. Yin, S. Mueller, E. Wimmer, and J. Cello. 2007. Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model. Cancer Res. 67:2857-2864.
58. Trono, D., R. Andino, and D. Baltimore. 1988. An RNA sequence of hundreds of nucleotides at the 5′ end of poliovirus RNA is involved in allowing viral protein synthesis. J. Virol. 62:2291-2299.
59. van der Werf, S., J. Bradley, E. Wimmer, F. W. Studier, and J. J. Dunn. 1986. Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 83:2330-2334.
60. Wimmer, E., C. U. T. Hellen, and X. M. Cao. 1993. Genetics of poliovirus. Annu. Rev. Genet. 27:353-436.
61. Wimmer, E., and A. Paul. 2010. The making of a picornavirus genome, p. 33-55. In E. Ehrenfeld, E. Domingo, and R. P. Roos (ed.), The picornaviruses. ASM Press, Washington, DC.
62. Yin, F. H., and N. B. Lomax. 1983. Host range mutants of human rhinovirus in which nonstructural proteins are altered. J. Virol. 48:410-418.
63. Yin, J., A. V. Paul, E. Wimmer, and E. Rieder. 2003. Functional dissection of a poliovirus cis-acting replication element [PV-cre(2C)]: analysis of single-and dual-cre viral genomes and proteins that bind specifically to PV-cre RNA. J. Virol. 77:5152-5166.
64. Yoshikawa, T., et al. 2006. Role of the alpha/beta interferon response in the acquisition of susceptibility to poliovirus by kidney cells in culture. J. Virol. 80:4313-4325.